Investigating the effect of injectable hyoscine on facilitating the intrauterine insemination process and reducing patient pain and cramps during and after intrauterine insemination

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240514061800N12

Enrollment

120

Registered

2026-04-23

Start date

2026-04-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine insemination. Normal Pregnancy

Interventions

Intervention 1: Intervention group: Patients two hours before intrauterine insemination receive hyoscine (Kimia Daru) injections. Intervention 2: Control group: Patients in this group do not receive

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Nulligravid infertile patients who have been selected for IUI treatment based on scientific criteria.

Exclusion criteria

Exclusion criteria: Infertile patients with uterine anomalies History of cervical abnormalities. History of cryosurgery and liposuction.

Design outcomes

Primary

Measure	Time frame
Pain control. Timepoint: 2 hours after intervention. Method of measurement: Using the VAS score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra heydar

Shahid Beheshti University of Medical Sciences

dr_zheidar@yahoo.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026